Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28132760 | 0.90 | ALDH1A1 (0.49) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL8279036 | 0.85 | ALDH1A1 (0.56) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL28319473 | 0.85 | SMN1; SMN2 (0.46) | ALDH1A1MAPK1L3MBTL1SLC15A1TDP1 | |
| SCHEMBL7667014 | 0.83 | ALDH1A1 (0.54) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL1268516 | 0.83 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL294341 | 0.83 | ALDH1A1 (0.73) | ALDH1A1MAPK1L3MBTL1SLC6A2SLC6A3 | |
| SCHEMBL9364881 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1SLC15A1ATM | |
| SCHEMBL14864158 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL17048768 | 0.83 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL3975330 | 0.82 | ALDH1A1 (0.56) | ALDH1A1MAPK1L3MBTL1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090209612-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2009-08-20 | — | — | US | claimed |
| EP-1756053-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | Ranbaxy Laboratories Limited (IN) | 2007-02-28 | — | — | EP | claimed |
| WO-2005118536-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2005-12-15 | — | — | WO | claimed |
| US-12565595-B2 | Aqueous coating material composition and method for forming multilayer coating film | KANSAI PAINT CO., LTD. (JP) | 2026-03-03 | — | — | US | disclosed |
| US-20250346779-A1 | Method of Forming A Coating Film | KANSAI PAINT CO LTD (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250340751-A1 | Automobile Body Coating Method | KANSAI PAINT CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| US-20250154374-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2025-05-15 | — | — | US | disclosed |
| EP-4481010-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | Kansai Paint Co., Ltd. (JP) | 2024-12-25 | — | — | EP | disclosed |
| CN-116829662-B | Aqueous coating composition and method for forming multilayer coating film | 关西涂料株式会社 | 2024-10-29 | — | — | CN | disclosed |
| EP-3689476-B1 | METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO LTD (JP) | 2024-10-02 | — | — | EP | disclosed |
| US-20240309239-A1 | AQUEOUS COATING MATERIAL COMPOSITION AND METHOD FOR FORMING MULTILAYER COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| US-20090209693-A1 | Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof | OSAKA INDUSTRIAL PROMOTION (JP) | 2009-08-20 | — | — | US | disclosed |
| US-20090209612-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2009-08-20 | — | — | US | disclosed |
| US-20090209612-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2009-08-20 | — | — | US | disclosed |
| WO-2009033561-A1 | SUBSTITUTED 6-PHEYLNICOTINIC ACIDS AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-03-19 | — | — | WO | disclosed |
| WO-2009033561-A1 | SUBSTITUTED 6-PHEYLNICOTINIC ACIDS AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-03-19 | — | — | WO | disclosed |
| EP-1905756-A1 | SILVER BETA-KETOCARBOXYLATE, MATERIAL COMPRISING THE SAME FOR FORMING SILVER METAL, AND USE THEREOF | OSAKA UNIVERSITY (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1756053-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | Ranbaxy Laboratories Limited (IN) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006110918-A1 | PYRROLE COMPOUNDS AND USES THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2006-10-19 | — | — | WO | disclosed |
| WO-2005118536-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | RANBAXY LABORATORIES LIMITED (IN) | 2005-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565595-B2 | Aqueous coating material composition and method for forming multilayer coating film | DRD2, CHRM1, PNMT | ALDH1A1 2369/4885MAPK1 1131/4885L3MBTL1 3045/4885 |
| US-20090209693-A1 | Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof | PCCA, BCKDK, MCCC2 | ALDH1A1 105/4885MAPK1 3827/4885L3MBTL1 2772/4885 |
| US-20090209612-A1 | PROCESS FOR THE PREPARATION OF ATORVASTATIN | HMGCR, DHCR7, LDLR | ALDH1A1 2416/4885MAPK1 1571/4885L3MBTL1 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.